s6y

CTI BIOPHARMA CORP

CIK
891293
Industry
Pharmaceutical Preparations
Formerly
CELL THERAPEUTICS INC

Financials 126

  1. 10-Q Quarterly Report for period ending Mar 31, 2023
  2. 10-K Annual Report for period ending Dec 31, 2022
  3. 10-Q Quarterly Report for period ending Sep 30, 2022
  4. 10-Q Quarterly Report for period ending Jun 30, 2022
  5. 10-Q Quarterly Report for period ending Mar 31, 2022
  6. 10-K Annual Report for period ending Dec 31, 2021
  7. 10-Q Quarterly Report for period ending Sep 30, 2021
  8. 10-Q Quarterly Report for period ending Jun 30, 2021
  9. 10-Q Quarterly Report for period ending Mar 31, 2021
  10. 10-K Annual Report for period ending Dec 31, 2020

All 126 financials filings

News 595

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 595 news filings

Ownership 995

  1. 4 Statement of changes in beneficial ownership of securities
  2. SC 13D/A Major Shareholders
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 995 ownership filings

Prospectus 304

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 304 prospectus filings

Proxies 144

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 144 proxies filings

Other 229

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. EFFECT Notice of Effectiveness
  10. EFFECT Notice of Effectiveness

All 229 other filings